Drug benefits in managed care: Seeking ethical guidance from the formulary?

Journal of the American Geriatrics Society

Volumn 46, Issue 3, 1998, Pages 346-350

  Fins, Joseph J ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DRUG CHOICE; HEALTH CARE QUALITY; INFORMED CONSENT; MANAGED CARE; MEDICAL DECISION MAKING; MEDICAL ETHICS; PATIENT CARE; PHARMACY; QUALITY OF LIFE;

EID: 0031882819     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01051.x     Document Type: Conference Paper

References (27)

1. Rodwin M. Medicine, Money and Morals. New York: Oxford University Press, 1993.
2. Gemignani J. PBMs. Why this exponential growth? Business Health March 1996: 53-55.
3. Fins JJ. Praxis makes perfect? Hastings Cent Rep 1992;23:16-19.
4. The New York Hospital Formulary and Therapeutics Committee. The New York Hospital Formulary 1992-1993.
5. Sanchez LA, Lee J. Use and misuse of pharmacoeconomic terms: A definitions primer. Top Hosp Pharm Manage 1994;13:11-22.
6. Hatoum HT, Freeman RA. The use of pharmacoeconomic data in formulary selection. Top Hosp Pharm Manage 1994;13:47-53.
7. Fins JJ. The rationing of health care: A doctor's dilemma. J Relig Health 1993;32:9-20.
8. Levy SB. Antibiotic availability and use: Consequences to man and his environment. J Clin Epidemiol 1991;44(suppl. II):83-87.
9. Daniels N. Why saying no to patients is so hard: Cost containment, justice, and provider autonomy. N Engl J Med 1986;314:1381-1383.
10. Fins JJ. The hospital as ecosystem. Ecosys Health 1995;1:255-259.
11. Fins JJ. Prescription for health care reform: A page from the formulary. Pharm Ther 1994;19:750-759.
12. Community Health Plan. Drug Formulary 1995. Tepper C, Dillon MJ, O'Neill JM, eds. Latham, NY: Department of Pharmacy Operations, 1995.
13. New York Life. NYLCare Health Plans. Prescription Formulary. Prepared by NYLCare Pharmacy and Therapeutics Committee and Express Scripts, Inc. 1996.
14. Private Healthcare Systems. 1996 Formulary. PCS Health Systems, Inc. 1995.
15. Schafermeyer KW. Basics of managed care claims processing: From claims payment to outcomes management. J Managed Care Pharm 1995;1:200-205.
16. Clouse J Pharmacoeconomics. A managed care perspective. Top Hosp Pharm Manage 1994;13:54-59.
17. Rupp MT. Pharmacy Benefits Managers. Presentation at The Hastings Center. February 2, 1996.
18. Freudenheim M. Not quite what the doctor ordered: Drug substitutions add to discord over managed care. The New York Times, Oct. 8, 1996, p D1.
19. Herbert B. Prescription switches. The New York Times, Dec. 27, 1996, p A39.
20. Council on Ethical and Judicial Affairs, American Medical Association. Ethical issues in managed care. JAMA 1995;273:330-335.
21. Emanuel EJ, Dubler NN. Preserving the physician-patient relationship in the era of managed care. JAMA 1995;273:323-329.
22. Rupp MT. Guidelines for evaluating preferred product programs. Georgia Pharm J 1995;273:330-335.
23. Did Medco show preference for Merck? Drug Topics, 1995; 273:7.
24. Horn SD, Sharkey PD, Tracy DM et al. Intended and unintended consequences of HMO cost-containment strategies: Results from the managed care outcomes project. Am J Managed Care 1996;2:253-264.
25. Winslow R. Limiting drugs a doctor orders may cost more. Wall Street Journal, March 20, 1996.
26. Kravitz RL, Romano P. Managed care cost containment and the law of unintended consequences. Am J Managed Care 1996;2:323-324.
27. Elements of these recommendations include excerpts and revisions to earlier recommendations made in: Fins JJ. Prescription for helth care reform: A page from the formulary. Pharm Ther 1994;19:750-759.